| | | SIRP beta 1 isoform 3 Protein, Human, Recombinant (His & Avi)
RHC-CD-3352
39.9 kDa (predicted). Due to glycosylation, the pr
SIRP-+¦-1 isoform 3, SIRP-+¦, SIRP-beta-1 isoform 3, SIRP-beta, Sirpb1a, SIRPB1, Sirpb, SIRP +¦1 Isoform 3, FLJ26614, DKFZp686A05192, CD172b, 9930027N05Rik SIRP beta 1 isoform 3 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-3418
39.9 kDa (predicted). Due to glycosylation, the pr
SIRP-+¦-1 isoform 3, SIRP-+¦, SIRP-beta-1 isoform 3, SIRP-beta, Sirpb1a, SIRPB1, Sirpb, SIRP +¦1 Isoform 3, FLJ26614, DKFZp686A05192, CD172b, 9930027N05Rik SIRP beta 1 Protein, Human, Recombinant (His & Avi)
RHC-CD-3513
40 kDa (predicted). Due to glycosylation, the prot
SIRP-+¦-1 isoform 3, SIRP-+¦, SIRP-beta-1 isoform 3, SIRP-beta, Sirpb1a, SIRPB1, Sirpb, SIRP +¦/CD172b, FLJ26614, DKFZp686A05192, CD172b, 9930027N05Rik SIRP beta 1 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-3450
40 kDa (predicted). Due to glycosylation, the prot
SIRP-+¦-1 isoform 3, SIRP-+¦, SIRP-beta-1 isoform 3, SIRP-beta, Sirpb1a, SIRPB1, Sirpb, SIRP +¦/CD172b, FLJ26614, DKFZp686A05192, CD172b, 9930027N05Rik SIRP beta 2 Protein, Human, Recombinant (hFc)
RHC-RP-0098
80-95 kDa (reducing condition)
SIRP-+¦-2, SIRPG, SIRP-beta-2, SIRP +¦2, SIRP beta 2, Signal-Regulatory Protein +¦-2, Signal-Regulatory Protein +¦2, Signal-Regulatory Protein Beta-2, Signal-Regulatory Protein Beta 2, PTPNS1L3, PTPN1L, dJ776F14.2 SIRP gamma Protein, Human, Recombinant (hFc)
RHC-RP-0346
80 kDa (reducing condition)
SIRP-+¦, SIRP-+¦-2, SIRP-Gamma, SIRPG, SIRP-Beta-2, SIRP-b2, SIRPB2, Signal-Regulatory Protein +¦, Signal-Regulatory Protein Gamma, Signal-Fegulatory Protein +¦-2, Signal-Fegulatory Protein Beta-2, CD172g, CD172 Antigen-Like Family Member B SIRP gamma Protein, Human, Recombinant (His & Avi)
RHC-RP-0263
39.7 kDa (predicted). Due to glycosylation, the pr
SIRPG, SIRP-B2, SIRP +¦/CD172g, SIRP +¦, SIRP +¦2, SIRP +¦ 2, SIRP gamma, SIRP beta 2, FLJ42230, Cripto-1, CD172g, bA77C3.1 SIRP gamma Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-RP-0331
39.7 kDa (predicted). Due to glycosylation, the pr
SIRPG, SIRP-B2, SIRP +¦/CD172g, SIRP +¦, SIRP +¦2, SIRP +¦ 2, SIRP gamma, SIRP beta 2, FLJ42230, Cripto-1, CD172g, bA77C3.1 SIRP gamma Protein, Human, Recombinant (His)
RHC-RP-0063
38.5 kDa (predicted); 45-48 kDa (reducing conditio
SIRP+¦, SIRPgamma, SIRP-B2, SIRPB2, SIRP +¦/SIRPG, signal-regulatory protein +¦, signal-regulatory protein gamma, CD172g, bA77C3.1 SIRT2 INHIBITOR,INACTIVE CONTROL,AGK7
CAS:304896-21-7
Trade Name: 2-cyano-3-[5-(2,5-dichlorophenyl)furan-2-yl]-N-quinolin-8-ylprop-2-enamide
Formula: C23H13Cl2N3O2
ACM304896217
434.3
AC1LRM6M, CTK8E9295, MCULE-2264029020, SIRT2 Inhibitor, Inactive Control, AGK7, (2E)-2-cyano-3-[5-(2,5-dichlorophenyl)furan-2-yl]-N-(quinolin-8-yl)prop-2-enamide, 2-cyano-3-[5-(2,5-dichlorophenyl)furan-2-yl]-N-(quinolin-8-yl)prop-2-enamide, SIS3
CAS:521984-48-5
Trade Name: 1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3-(1-methyl-2-phenylpyrrolo[2,3-b]pyridin-3-yl)pro
Formula: C28H27N3O3HCl
ACM521984485
489.99
SIS3 hydrochloride, AGN-PC-00SMAM, SureCN6488325, CTK8E8838, 521984-48-5, (E)-1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3-(1-methyl-2-phenylpyrrolo[2,3-b]pyridin-3-yl)prop-2-en-1-one;hydrochloride SISOMICIN
CAS:53179-09-2
Trade Name: (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyr
Formula: 2C19H37N5O7.5H2O4S
APS53179092A
1385.45
Baymicin, Mensiso, Sisolline, Extramycin, Sisomycin sulfate, Sisobiotic, Sisomicin sulfate, Sisomin,Antibiotic 66-40 sulfate, D-Streptamine, O-3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1GåÆ6)-O-[2,6-diamino-2,3,4,6-tetradeox SISOMICIN BASE
CAS:32385-11-8
Formula: C19H37N5O7
PR32385118
447.53
((1S,2S,3R,4S,6R)-4,6-diamino-3-[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yloxy]-2-hydroxycyclohexyl3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranoside;O-2,6-Diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosy SISOMICIN SULFATE
CAS:53179-09-2
Formula: C19H39N5O11S
PR53179092
545.61
(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;sulfuricacid; SISOMICIN SULFATE
CAS:53179-09-2
Trade Name: (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyr
Formula: 2C19H37N5O7.5H2O4S
APS53179092
1385.45
Mensiso,Antibiotic 66-40 sulfate, D-Streptamine, O-3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1GåÆ6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1GåÆ4)]-2-deoxy-, sulfate (2:5), Sisolline, Sisomin, D-S SITAGLIPTIN
CAS:486460-32-6
Trade Name: (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trif
Formula: C16H15F6N5O
APS486460326
407.31
1,2,4-Triazolo[4,3-a]pyrazine, 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)- (9CI), 3(R)-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorop Sitagliptin N-sulfate
CAS:940002-57-3
Trade Name: [(2R)-4-oxo-4-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-1-(2,4,5-trifl
Formula: C16H15F6N5O4S
ACM940002573
487.38
N-[(1R)-3-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]sulfamic Acid; Sitagliptin carbamoyl +¦-D-glucuronide
CAS:940002-59-5
Trade Name: (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[[(2R)-4-oxo-4-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazo
Formula: C23H23F6N5O9
ACM940002595
627.45
1-[N-[(1R)-3-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]carbamate] SITAGLIPTIN PHOSPHATE MONOHYDRATE
CAS:654671-77-9
Trade Name: (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trif
Formula: C16H15F6N5O.H2O.H3O4P
APS654671779
523.32
1,2,4-Triazolo[4,3-a]pyrazine, 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-, phosphate (1:1), monohydrate (9CI), (2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7( SITAGLIPTIN TRIAZECINE ANALOG
Trade Name: 3-(trifluoromethyl)-10-[(2,4,5-trifluorophenyl)methyl]-5,6,7,9,10,11-hexahydro-[1,2,4]triazolo[3,4-c
Formula: C16H13F6N5O2
APS003063
421.30 SITAGLIPTIN-D4 PHOSPHATE
CAS:1432063-88-1
Trade Name: (3R)-3-amino-1-[5,5,6,6-tetradeuterio-3-(trifluoromethyl)-8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(
Formula: C162H4H11F6N5O.H3O4P
APS1432063881
509.33
Sitagliptin-D4 phosphate (5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl-5,5,6,6-D4), (3R)-3-Amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl-5,5,6,6-d4]-4-(2,4,5-trifluorophenyl)-1-butanone phosphate, Sita SITOINDOSIDE I
CAS:18749-71-8
Trade Name: [(2R,3S,4S,5R,6R)-6-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dime
Formula: C51H90O7
ACM18749718
815.3
6-naphthalen-2-ylamino-1H-pyrimidine-2,4-dione; SITOINDOSIDE I
CAS:18749-71-8
Trade Name: [(2R,3S,4S,5R,6R)-6-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dime
Formula: C51H90O7
ACM18749718
815.3
6-naphthalen-2-ylamino-1H-pyrimidine-2,4-dione; SITOINDOSIDE I
CAS:18749-71-8
Trade Name: [(2R,3S,4S,5R,6R)-6-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dime
Formula: C51H90O7
FFC-AR-18749718
815.27
Sitosteryl (6'-O-palmitoyl)-3-+¦-D-glucopyranoside SITOLACTONE
CAS:64053-02-7
Formula: C13H18O3
PR64053027
222.28
(4aS,6aR,9aR,9bR)-Decahydro-6a-methylcyclopenta[f][1]benzopyran-3,7-dione;+¦-Lactone;Cyclopenta[f][1]benzopyran-3,7-dione,decahydro-6a-methyl-,(4aS,6aR,9aR,9bR)-; SITOSTANOL
CAS:83-45-4
Trade Name: (3S,5S,8R,9S,10S,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,
Formula: C29H52O
ACM83454-2
416.72
Stigmastanoldihydrositosterol; (3+¦)-Stigmastan-3-ol; (3+¦,5+¦)-Stigmastan-3-ol SITOSTANOL
CAS:83-45-4
Trade Name: (3S,5S,8R,9S,10S,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,
Formula: C29H52O
FFC-AR-83454
416.72
24+¦-ethyl Cholestanol SITOSTANOL
CAS:83-45-4
Trade Name: IUPAC Name: (3S,5S,8R,9S,10S,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,
Formula: C29H52O
BM-DEL-83454
416.7g/mol
24-Ethyl-5+¦(H)-cholestan-3-ol (+¦-Sitostanol) SITOSTENONE
CAS:1058-61-3
Trade Name: (8S,9S,10R,13R,14S)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,
Formula: C29H48O
ACM1058613
412.7 SITOSTENONE
CAS:1058-61-3
Trade Name: (8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14
Formula: C29H48O
FFC-AR-1058613
412.69
(24R)-24-Ethylcholest-4-en-3-one SITOSTEROL
CAS:83-46-5
Trade Name: (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12
Formula: C29H50O
ACM83465-2
414.71
22,23-Dihydrostigmasterol; Stigmast-5-en-3+¦-ol+¦-sitosterin SITOSTEROL-25,26,26,26,27,27,27-D7
Formula: C29D7H50O
ACMA00061232
421.76
5-Cholesten-24(RS)-ethyl-3+¦-ol-25,26,26,26,27,27,27-d7;24-Ethylcholesterol-25,26,26,26,27,27,27-d7 SITOSTERYL PALMITATE
CAS:2308-85-2
Trade Name: [(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,1
Formula: C45H80O2
FFC-AR-2308852
653.12
(3+¦)-Stigmast-5-en-3-ylpalmitate SITOSTERYL PALMITATE
CAS:2308-85-2
Trade Name: [(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,1
Formula: C45H80O2
ACM2308852
653.1 SITS
CAS:51023-76-8
Trade Name: 5-acetamido-2-[(E)-2-(4-isothiocyanato-2-sulfophenyl)ethenyl]benzenesulfonic acid
Formula: C17H12N2Na2O7S3
ACM51023768
498.46
SITS, IADS, AIDS002741, AIDS-002741, NSC328387 (FREE ACID), CID5282250, NSC 328387, 27816-59-7 (FREE ACID), C13702, 51023-76-8 (DISODIUM SALT, HYDRATE), 4-Acetamido-4-isothiocyanatostilbene-2,2-disulfonic acid, 4-Acetamido-4-isothiocyanosti SJ000025081
CAS:421571-66-6
Trade Name: propyl 7-(3,4-dimethoxyphenyl)-4-(2-fluorophenyl)-2-methyl-5-oxo-4,6,7,8-tetrahydro-1H-quinoline-3-c
Formula: C28H30FNO5
ACM421571666
479.54
GNF-Pf-5668, ST50009781, SJ000025081, BAS 01547495, AC1MJ79A, NKY80, Oprea1_616933, Oprea1_633811, CHEMBL579338, CHEMBL602521, MolPort-000-906-806, STK081142, AKOS000537713, MCULE-1174085014, EU-0010235, AG-690/40696399, 2-Amino-7-(2-furany SKF 91488 2HCL
CAS:68643-23-2
Trade Name: 4-(dimethylamino)butyl carbamimidothioate
Formula: C7H17N3S
ACM68643232
175.298
Tocris-0512, Lopac-S-145, Lopac0_001172, SKF 91488 dihydrochloride, SKF 91488, C7H17N3S, SK&F 91488, dihydrobromide, SK&F 91488, SK&F 91488, dihydrochloride, CID5227, SK&F-91488, SKF-91488, 4-(Dimethylamino)butyl carbamimidothioate, NCGC000 SKF-75670 HYDROBROMIDE
CAS:62717-63-9
Trade Name: 3-methyl-5-phenyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide
Formula: C17H19NO2?HBr
ACM62717639
350.250200 [g/mol]
SKF 75670 hydrobromide, SKF-75670 hydrobromide, MLS002172465, S2941_SIGMA, Skf 75670, MolPort-003-959-527, CID173870, SKF-75670, SK&F 75670, NCGC00094362-01, SMR001254096, EU-0101087, S 2941, 7,8-dihydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahyd SLAMF3 Protein, Mouse, Recombinant (His)
RHC-CD-3578
65-75 kDa (reducing condition)
T-lymphocyte surface antigen Ly-9, SLAMF3, SLAM family member 3, Signaling lymphocytic activation molecule 3, Lymphocyte antigen 9, Ly-9, Ly9, Cell surface molecule Ly-9, CD229 SLAMF5 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-0049
40-50 kDa (reducing condition)
SLAMF5, SLAM family member 5, Signaling lymphocytic activation molecule 5, Leukocyte differentiation antigen CD84, Hly9-+¦, Hly9-beta, Cell surface antigen MAX.3, CD84 SLAMF6 Protein, Cynomolgus, Recombinant (His)
RHC-CD-3509
23.98 kDa (predicted). Due to glycosylation, the p
SLAMF6, SF2000, NTB-A, NK-T-B-antigen, Ly108, KALIb, KALI, CD352, ANK-T-B-antigen SLAMF6 Protein, Human, Recombinant (His & Avi)
RHC-CD-3448
26 kDa (predicted). Due to glycosylation, the prot
SLAMF6, SF2000, NTB-A, NK-T-B-antigen, Ly108, KALIb, KALI, CD352, ANK-T-B-antigen SLAMF6 Protein, Mouse, Recombinant (aa 31-239, His)
RHC-CD-3462
24.03 kDa (predicted). Due to glycosylation, the p
SLAMF6, SF2000, NTB-A, NK-T-B-antigen, Ly108, KALIb, KALI, CD352, ANK-T-B-antigen SLAMF7 Protein, Cynomolgus, Recombinant (His)
RHC-CART-0368
23.55 kDa (predicted). Due to glycosylation, the p
SLAMF7, Novel Ly9, FOAP-12, CS1, CRACC, CD319, CD2 subset 1, 19A SLAMF7 Protein, Human, Recombinant (His & Avi)
RHC-CART-0264
25.3 kDa (predicted). Due to glycosylation, the pr
SLAMF7, Novel Ly9, FOAP-12, CS1, CRACC, CD319, CD2 subset 1, 19A SLAMF7 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CART-0294
35-55 kDa (reducing condition)
SLAMF7, SLAM Family Member 7, Protein 19A, Novel Ly9, Membrane Protein FOAP-12, CS1, CRACC, CD319, CD2-Like Receptor-Activating Cytotoxic Cells, CD2 Subset 1 SLAMF7 Protein, Human, Recombinant (mFc)
RHC-CART-0374
60-90 kDa (reducing condition)
SLAMF7, SLAM Family Member 7, Protein 19A, Novel Ly9, Membrane Protein FOAP-12, CS1, CRACC, CD319, CD2-Like Receptor-Activating Cytotoxic Cells, CD2 Subset 1 SLAMF7 Protein, Rhesus macaque, Recombinant (His)
RHC-CART-0317
30-50 kDa (reducing condition)
SLAMF7, SLAM Family Member 7, Protein 19A, Novel Ly9, Membrane Protein FOAP-12, CS1, CRACC, CD319, CD2-Like Receptor-Activating Cytotoxic Cells, CD2 Subset 1 SLOTOXIN
CAS:401470-29-9
Trade Name: (8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7
Formula: C22H29FO5
ACM401470299
392.461063;g/mol SLV-306
CAS:182821-27-8
Trade Name: 2-[(3S)-3-[[1-[(2R)-2-ethoxycarbonyl-4-phenylbutyl]cyclopentanecarbonyl]amino]-2-oxo-4,5-dihydro-3H-
Formula: C31H38N2O6
ACM182821278
534.643220 [g/mol]
Daglutril, SLV-306, SLV306, UNII-KKV299446X, CID3038505, LS-182213, 1H-1-Benzazepine-1-acetic acid, 3-(((1-((2R)-2-(ethoxycarbonyl)-4-phenylbutyl)cyclopentyl)carbonyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (3S)-, 1H-1-Benzazepine-1-acetic acid, SM68 Standard 1: Al,As,B,Ba,Be,Bi,Ca,Cd,Ce,Co,Cr,Cs,Cu,Dy,Er,Eu,Fe,Ga,Gd,Ho,In,K,La,Li,Lu,Mg,Mn,Na,Nd,Ni,P,Pb,Pr,Rb,Re,Sc,Se,Sm,Sr,Tb,Th,Tl,Tm,U,V,Y,Yb,Zn @ 100 -¦g/mL in 5% HNO3
APS003069 SM68 Standard 2: Ag, Ge, Hf, Mo, Nb, Sb, Si, Sn, Ta, Ti, W, Zr @ 100 -¦g/mL in 5% HNO3, tr. HF
APS003070 SMAD1 Protein, Human, Recombinant (GST)
RHC-ENZY-2554
58-80 kDa (reducing condition)
Transforming Growth Factor-+¦-Signaling Protein 1, Transforming Growth Factor-Beta-Signaling Protein 1, SMAD1, SMAD Family Member 1, SMAD 1, Mothers Against DPP Homolog 1, Mothers Against Decapentaplegic Homolog 1, Mad-Related Protein 1, MAD SMAD3 Protein, Human, Recombinant (His & Flag)
RHC-CGF-1114
50-60 kDa (reducing condition)
SMAD3, SMAD family member 3, SMAD 3, Mothers against DPP homolog 3, Mothers against decapentaplegic homolog 3, MADH3, Mad3, MAD homolog 3, JV15-2, hSMAD3, hMAD-3 SMAD4 Protein, Human, Recombinant (His)
RHC-CGF-1119
62 kDa (reducing condition)
SMAD4, SMAD Family Member 4, SMAD 4, Mothers Against DPP Homolog 4, Mothers Against Decapentaplegic Homolog 4, MADH4, MAD Homolog 4, hSMAD4, DPC4, Deletion Target in Pancreatic Carcinoma 4 SMDPPEH
CAS:1093468-95-1
Trade Name: 2,5-bis(2-ethylhexyl)-1,4-bis[5-[5-(5-hexylthiophen-2-yl)thiophen-2-yl]thiophen-2-yl]pyrrolo[3,4-c]p
Formula: C58H72N2O2S6
ACM1093468951-1
1021.59
2,5-Di-(2-ethylhexyl)-3,6-bis-(5''-n-hexyl-[2,2',5',2'']terthiophen-5-yl)-pyrrolo[3,4-c]pyrrole-1,4-dione SMDPPEH
CAS:1093468-95-1
Trade Name: 2,5-bis(2-ethylhexyl)-1,4-bis[5-[5-(5-hexylthiophen-2-yl)thiophen-2-yl]thiophen-2-yl]pyrrolo[3,4-c]p
Formula: C58H72N2O2S6
ACM1093468951-1
1021.59
2,5-Di-(2-ethylhexyl)-3,6-bis-(5''-n-hexyl-[2,2',5',2'']terthiophen-5-yl)-pyrrolo[3,4-c]pyrrole-1,4-dione SMDPPO
CAS:1435933-95-1
Trade Name: 1,4-bis[5-[5-(5-hexylthiophen-2-yl)thiophen-2-yl]thiophen-2-yl]-2,5-dioctylpyrrolo[3,4-c]pyrrole-3,6
Formula: C58H72N2O2S6
ACM1435933951
1021.6g/mol
2,5-Dioctyl-3,6-bis-(5''-n-hexyl-[2,2',5',2'']terthiophen-5-yl)-pyrrolo[3,4-c]pyrrole-1,4-dione SMDPPO
CAS:1435933-95-1
Trade Name: 1,4-bis[5-[5-(5-hexylthiophen-2-yl)thiophen-2-yl]thiophen-2-yl]-2,5-dioctylpyrrolo[3,4-c]pyrrole-3,6
Formula: C58H72N2O2S6
ACM1435933951
1021.6g/mol
2,5-Dioctyl-3,6-bis-(5''-n-hexyl-[2,2',5',2'']terthiophen-5-yl)-pyrrolo[3,4-c]pyrrole-1,4-dione SMER 3
CAS:67200-34-4
Trade Name: 13-oxa-10,12,14,16-tetrazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11,14-heptaen-8-one
Formula: C11H4N4O2
PR67200344
224.18
9H-Indeno[1,2-e][1,2,5]oxadiazolo[3,4-b]pyrazin-9-one SMIFH2
CAS:340316-62-3
Trade Name: (5E)-1-(3-bromophenyl)-5-(furan-2-ylmethylidene)-2-sulfanylidene-1,3-diazinane-4,6-dione
Formula: C15H9BrN2O3S
ACM340316623
377.21
STK197413, ZINC01203437, SMIFH2, AC1M4GYW, MolPort-002-178-894, (5E)-1-(3-bromophenyl)-5-(furan-2-ylmethylidene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione, AKOS001651888, BIM-0040107.P001, (5E)-1-(3-bromophenyl)-5-(furan-2-ylmethylidene)-2 SN 003
CAS:197801-88-0
Trade Name: 1-(1-methoxybutan-2-yl)-N-(4-methoxy-2-methylphenyl)-6-methyltriazolo[4,5-c]pyridin-4-amine
Formula: C19H25N5O2
ACM197801880
355.43
CHEMBL2221285, MolPort-023-276-739, SN003, PDSP1_001298, PDSP2_001282, SN 003, AKOS024457532, 197801-88-0, N-(4-Methoxy-2-methylphenyl)-1-[1-(methoxymethyl)propyl]-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine SN(IV)MESO-TETRA(4-PYRIDYL)PORPHINE DICHLORIDE
CAS:87261-83-4
Trade Name: (1Z,6Z,12Z,17Z)-22,22-Dichloro-2,7,12,17-tetra(4-pyridinyl)-21,23,24,2...
Formula: C40H24Cl2N8Sn
ACM87261834
806.29
dichloro-(4-chloro-phenoxy)-[1,3,5]triazine; Sn(IV) tetrakis(4-pyridyl)porphyrin dichloride; 2-(4-Chlorphenoxy)-4,6-dichlor-s-triazin; dichloro-(5,10,15,20-tetrakis-(4-pyridyl)-porphyrinato)tin(IV); 2,4-dichloro-6-(4-chloro-phenoxy)-[1,3,5] SN-38
CAS:86639-52-3
Trade Name: (S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
Formula: C22H20N2O5
APS86639523
392.40
7-Ethyl-10-hydroxycamptothecin, 10-Hydroxy-7-ethylcamptothecin,(S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 7-Ethyl-10-hydroxy-20(S)-camptothecin, 11-Ethyl-9-hydroxycamptothecin, (4S)-4,1 SN-38 GLUCURONIDE
CAS:121080-63-5
Formula: C28H28N2O11
ACM121080635
568.53
SN-38 GLUCURONIDE;(4S)-4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3,4:6,7]indolizino[1,2-b]quinolin-9-yl +¦-D-Glucopyranosiduronic Acid;4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3,4:6,7]indolizino Sn-38 tri-O-acetyl-+¦-D-glucuronic acid methyl ester
CAS:121098-77-9
Trade Name: SN-38 Tri-O-acetyl-+¦-D-glucuronic Acid Methyl Ester
Formula: C35H36N2O14
ACM121098779
708.67
(S)-4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl +¦-D-Glucopyranosiduronic Acid Methyl Ester 2,3,4-Triacetate; SN-38-D3 GLUCURONIDE
Formula: C28H25D3N2O11
ACMA00061243
571.55
4-Ethyl-11-(ethyl-d3)-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 4-Deoxy-+¦-D-glucopyranosiduronic Acid; (4S)-4-Ethyl-11-(ethyl-d3)-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6 SN-38-D5 GLUCURONIDE
Formula: C28H23D5N2O11
ACMA00061245
573.56
4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl +¦-D-Glucopyranosiduronic Acid-d5; (4S)-4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]qui SNAP-25 Protein, Human, Recombinant (His)
RHC-OTH-0055
24.8 kDa (predicted); 28 kDa (reducing conditions)
synaptosomal-associated protein, 25kDa, SNAP-25, SNAP, SEC9, RIC-4, RIC4, dJ1068F16.2, bA416N4.2 SNCL2PC
CAS:18253-54-8
Trade Name: 38,38-dichloro-9,18,27,36,37,39,40,41-octaza-38-stannadecacyclo[17.17.3.110,17.128,35.02,7.08,37.011
Formula: C32H16Cl2N8Sn
ACM18253548-2
702.14
31h-phthalocyaninato(2-)-n29,n39,n31,n32]-dichloro[29(oc-6-12)-ti;dichloro[29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-,(OC-6-12)-Tin;Dichloro[phthalocyaninato(2-)]-tin(IV);PHTHALOCYANATODICHLOROTINIV;PHTHALOCYANINETIN(4)DICHLORIDE;PHTHAL SNCL2PC
CAS:18253-54-8
Trade Name: 38,38-dichloro-9,18,27,36,37,39,40,41-octaza-38-stannadecacyclo[17.17.3.110,17.128,35.02,7.08,37.011
Formula: C32H16Cl2N8Sn
ACM18253548-2
702.14
31h-phthalocyaninato(2-)-n29,n39,n31,n32]-dichloro[29(oc-6-12)-ti;dichloro[29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-,(OC-6-12)-Tin;Dichloro[phthalocyaninato(2-)]-tin(IV);PHTHALOCYANATODICHLOROTINIV;PHTHALOCYANINETIN(4)DICHLORIDE;PHTHAL SOD1 Protein, Human, Recombinant (His)
RHC-ENZY-0205
16.8 kDa (predicted); 20 kDa (reducing conditions)
superoxide dismutase 1, soluble, SOD, IPOA, hSod1, homodimer, HEL-S-44, ALS1, ALS Sodium (2R)-2,3-bis{[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxy}propyl hydrogen phosphate
CAS:474943-33-4
Trade Name: Sodium;[(2R)-2,3-bis[[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxy]propyl] hydrogen phosphate
Formula: C43H68NaO8P
ACM474943334
767
20:4 PA Sodium (2S,8R,13Z,16Z,19Z,22Z,25Z,28Z)-2-azaniumyl-8-[(hexadecanoyloxy)methyl]-5-oxido-5,10-dioxo-4,6,9-trioxa-5lambda-5-phosphahentriaconta-13,16,19,22,25,28-hexaen-1-oate
CAS:474943-17-4
Trade Name: Sodium;(2S)-2-azaniumyl-3-[[(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-h
Formula: C44H73NNaO10P
ACM474943174
830
16:0-22:6 PS Sodium (2S,8R,13Z,16Z,19Z,22Z,25Z,28Z)-2-azaniumyl-8-[(octadecanoyloxy)methyl]-5-oxido-5,10-dioxo-4,6,9-trioxa-5lambda-5-phosphahentriaconta-13,16,19,22,25,28-hexaen-1-oate
CAS:474943-18-5
Trade Name: Sodium;(2S)-2-azaniumyl-3-[[(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-o
Formula: C46H77NNaO10P
ACM474943185
858.1
18:0-22:6 PS Sodium (2S,8R,14Z,17Z,20Z,23Z)-2-azaniumyl-8-[(octadecanoyloxy)methyl]-5-oxido-5,10-dioxo-4,6,9-trioxa-5lambda-5-phosphanonacosa-14,17,20,23-tetraen-1-oate
CAS:474967-15-2
Trade Name: Sodium;(2S)-2-azaniumyl-3-[[(2R)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxy-3-octadecanoyloxy
Formula: C44H77NNaO10P
ACM474967152
834
18:0-20:4 PS Sodium +¦-glucoheptonat
CAS:13007-85-7
Trade Name: sodium;(2R,3R,4S,5R,6R)-2,3,4,5,6,7-hexahydroxyheptanoate
Formula: C7H13NaO8
BBC13007857
248.16
D-Glycero-D-gulo-heptonicacid,monosodiumsalt |
